Category Archives: Publications & Research
Restrictions Sought on Fingolimod for MS Part 2
This articles continues on from Restrictions Sought on Fingolimod for MS Part 1. The Institute for Safe Medication Practices (ISMP) has urged the US Food and Drug Administration (FDA) to restrict the use of fingolimod (Gilenya, Novartis) in patients with … Continue reading
Click to Chat